Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials. - Wikidata - awgldk - TriplyDB

Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials.

Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials.

http://www.wikidata.org/entity/Q34441060

about

Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients.Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data Excess mortality in patients diagnosed with hypothyroidism: a nationwide cohort study of singletons and twins.Why is greater medication adherence associated with better outcomes.Validity of medication adherence self-reports in adults with type 2 diabetes.Association between teriparatide treatment persistence and adherence, and fracture incidence in Taiwan: analysis using the National Health Insurance Research Database A nested case-control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I-III breast cancer.Associations between exemption and survival outcomes in the UK's primary care pay-for-performance programme: a retrospective cohort study.Adherence, expectations and the placebo response: why is good adherence to an inert treatment beneficial?The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis.Adherence with medications used to treat osteoporosis: behavioral insights.Low Blood Pressure Is Associated With Greater Risk for Cardiovascular Events in Treated Adults With and Without Apparent Treatment-Resistant Hypertension.Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.Osteoporosis: Treat or Let Die Twice More Likely.Statin use does not protect from fractures: the healthy adherer effect is a plausible explanation in observational studies.Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients-a nationwide register-based open cohort study.Incidence of atypical nontraumatic diaphyseal fractures of the femur.It's Bad-Really Bad-But Does it Matter? Medication Adherence in Chronic Obstructive Pulmonary Disease.

P2860

Q34007066-C8C1AC50-0F0C-48E6-AF4B-A4A2D388472C Q34316224-30F8F946-69ED-43CD-9840-A4A496362DEC Q36663045-2531E915-DA14-4493-AC72-3C4E99953789 Q36707347-86C900A3-32F6-4962-ACFD-308DBB9924FE Q36720420-D692A6A3-1A31-4D6A-B8C6-9AC043E1BE58 Q37168515-D7BF9088-DA52-449F-B942-D7B49AAB0A54 Q37182304-C3925680-A33B-48ED-856B-32E98B74F5F8 Q37235872-DC5B4814-2BDC-4FF0-A531-433805D51C1C Q37365722-861F8085-84AF-4D14-9F93-D77CF8131385 Q37998122-2FC645BA-768D-4C4B-8103-3858A40C38E7 Q38075457-0C35F211-BE50-4C6C-A9ED-9E38AC36ED99 Q39262972-88663790-43E0-4A9B-8AE5-AD8A5535B485 Q40305276-B20E956C-7EA1-49C7-826F-854B3640B2C4 Q41546766-665D2354-0EDD-4F3D-B74B-3DE93AFED0A1 Q42344038-397A2517-CD59-469F-84D8-70880CFB98E7 Q42650607-3226E2DB-A383-4A7E-82A7-B54DA67A9781 Q44364497-CDEA77B0-6637-4CAE-B1B1-906E78A20A2B Q47886032-ECFC02E1-9C98-4474-BB7B-526CED1BC404

P2860

Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials.

http://www.wikidata.org/entity/Q34441060

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Placebo adherence, clinical ou ...... omized hormone therapy trials.

@ast

Placebo adherence, clinical ou ...... omized hormone therapy trials.

@en

Placebo adherence, clinical ou ...... omized hormone therapy trials.

@nl

type

label

Placebo adherence, clinical ou ...... omized hormone therapy trials.

@ast

Placebo adherence, clinical ou ...... omized hormone therapy trials.

@en

Placebo adherence, clinical ou ...... omized hormone therapy trials.

@nl

prefLabel

Placebo adherence, clinical ou ...... omized hormone therapy trials.

@ast

Placebo adherence, clinical ou ...... omized hormone therapy trials.

@en

Placebo adherence, clinical ou ...... omized hormone therapy trials.

@nl

P1433

Q34441060-72D9717A-8106-4E1D-A5C9-6C9F43E16D31

P1476

Q34441060-CE9F4934-19DF-497E-BA78-4D949B1D752C

P2093

Q34441060-160D0464-1446-41E2-8589-17E96CDB6B86

Q34441060-2A3A8B0B-45B9-42A5-AC48-8453A7EDF4EC

Q34441060-5C607697-B9C9-4211-8DFB-FC957DBEE6A5

Q34441060-72721BE2-A278-4FB6-8914-A9597E85DFF8

Q34441060-A2579845-92C8-4549-ABBE-DEFF5F46C52C

Q34441060-A2F52FEB-E076-40EA-892B-853AFE8AD88D

Q34441060-BB0C8660-2727-4BE0-B767-48893358D32C

Q34441060-C23226F0-DEA0-4DCD-88A4-25B3F3DCEE0A

Q34441060-D850A89B-92D5-42A6-B23E-52BBDE0F681A

P2860

Q34441060-0F38F3C2-2EF9-4D6D-8263-BB0FB3017E2A

Q34441060-16F9E5F6-9CA6-43FB-AFB5-9D6F0E66E98C

Q34441060-190BACD2-C639-41C3-9383-E67A773ABF7C

Q34441060-1A17BF47-A886-43C3-A848-027949520025

Q34441060-1A1F9FA9-AA52-40EC-A64C-237F396AD9FF

Q34441060-1EE07E8A-1641-4AB0-AD65-FE45DBE14AA6

Q34441060-213207A9-F004-4078-A468-847054ECEB30

Q34441060-2F5511A9-1B69-43BD-AC10-E8CE129173FE

Q34441060-32D4F122-173F-4A6E-8F2C-427EF6363180

Q34441060-39279014-21D2-4792-87DD-7CD659922EE5

P304

Q34441060-ECB4A3DC-C41E-4A79-9AF2-132CDD4FC9E7

P31

Q34441060-EC8F2E69-6262-47DB-8F19-6EA228BB6FEB

P356

Q34441060-EFAB5EC7-83A1-45CD-8798-2882CB8250AF

P433

Q34441060-638A417F-E948-4E60-9B21-9345B2BD9589

P478

Q34441060-04BA5C69-4B4A-4B3A-B2AD-81FCDC069423

P50

Q34441060-B2B57428-D76A-4AB8-9907-FA997947B01E

P577

Q34441060-973D5206-C697-4580-BD3A-957A5DBE7115

P698

Q34441060-58D05373-1D6F-4E5E-B485-7D6764454C53

P921

Q34441060-46165AF3-D45B-4E90-9795-B88FB0282CBA

P932

Q34441060-E3239B2C-090F-443A-9F6F-02FD63B547C9

P356

MLR.0B013E318207ED9E

P1433

P1476

Placebo adherence, clinical ou ...... omized hormone therapy trials.

@en

P2093

Andrea Z Lacroix

http://www.w3.org/2001/XMLSchema#string

Daniel H Solomon

http://www.w3.org/2001/XMLSchema#string

Elizabeth Delzell

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Curtis

http://www.w3.org/2001/XMLSchema#string

Joseph C Larson

http://www.w3.org/2001/XMLSchema#string

Maurice Alan Brookhart

http://www.w3.org/2001/XMLSchema#string

Rowan Chlebowski

http://www.w3.org/2001/XMLSchema#string

Suzanne Judd

http://www.w3.org/2001/XMLSchema#string

Suzanne M Cadarette

http://www.w3.org/2001/XMLSchema#string

P2860

A meta-analysis of the association between adherence to drug therapy and mortality

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction

Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.

Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.

Calcium plus vitamin D supplementation and the risk of fractures.

P304

427-435

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MLR.0B013E318207ED9E

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Monika M Safford

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21422960

http://www.w3.org/2001/XMLSchema#string

P921

P932

4217207

http://www.w3.org/2001/XMLSchema#string